 | • レポートコード：MRC2Q12-19423 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、片頭痛用トリプタンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 片頭痛用トリプタンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 片頭痛用トリプタンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 片頭痛用トリプタンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの片頭痛用トリプタンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の片頭痛用トリプタンの売上および2028年までの予測に焦点を当てています。 片頭痛用トリプタンのグローバル主要企業には、GSK、Teva、Pfizer、Novartis、Sun Pharma、Grunenthal、Endo Pharmaceuticals、Merck、Johnson & Johnsonなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 片頭痛用トリプタン市場は、タイプとアプリケーションによって区分されます。世界の片頭痛用トリプタン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 経口、皮下注射、その他 【アプリケーション別セグメント】 病院薬局、ドラッグストア 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 片頭痛用トリプタン製品概要 - タイプ別市場（経口、皮下注射、その他） - アプリケーション別市場（病院薬局、ドラッグストア） - 調査の目的 ・エグゼクティブサマリー - 世界の片頭痛用トリプタン販売量予測2017-2028 - 世界の片頭痛用トリプタン売上予測2017-2028 - 片頭痛用トリプタンの地域別販売量 - 片頭痛用トリプタンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別片頭痛用トリプタン販売量 - 主要メーカー別片頭痛用トリプタン売上 - 主要メーカー別片頭痛用トリプタン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（経口、皮下注射、その他） - 片頭痛用トリプタンのタイプ別販売量 - 片頭痛用トリプタンのタイプ別売上 - 片頭痛用トリプタンのタイプ別価格 ・アプリケーション別市場規模（病院薬局、ドラッグストア） - 片頭痛用トリプタンのアプリケーション別販売量 - 片頭痛用トリプタンのアプリケーション別売上 - 片頭痛用トリプタンのアプリケーション別価格 ・北米市場 - 北米の片頭痛用トリプタン市場規模（タイプ別、アプリケーション別） - 主要国別の片頭痛用トリプタン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの片頭痛用トリプタン市場規模（タイプ別、アプリケーション別） - 主要国別の片頭痛用トリプタン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の片頭痛用トリプタン市場規模（タイプ別、アプリケーション別） - 主要国別の片頭痛用トリプタン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の片頭痛用トリプタン市場規模（タイプ別、アプリケーション別） - 主要国別の片頭痛用トリプタン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの片頭痛用トリプタン市場規模（タイプ別、アプリケーション別） - 主要国別の片頭痛用トリプタン市場規模（トルコ、サウジアラビア） ・企業情報 GSK、Teva、Pfizer、Novartis、Sun Pharma、Grunenthal、Endo Pharmaceuticals、Merck、Johnson & Johnson ・産業チェーン及び販売チャネル分析 - 片頭痛用トリプタンの産業チェーン分析 - 片頭痛用トリプタンの原材料 - 片頭痛用トリプタンの生産プロセス - 片頭痛用トリプタンの販売及びマーケティング - 片頭痛用トリプタンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 片頭痛用トリプタンの産業動向 - 片頭痛用トリプタンのマーケットドライバー - 片頭痛用トリプタンの課題 - 片頭痛用トリプタンの阻害要因 ・主な調査結果 |
Triptans are a family of tryptamine-based drugs used as abortive medication in the treatment of migraines and cluster headaches.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Triptans for Migraine Headaches is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Triptans for Migraine Headaches is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Triptans for Migraine Headaches is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Triptans for Migraine Headaches include GSK, Teva, Pfizer, Novartis, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Merck and Johnson & Johnson, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Triptans for Migraine Headaches manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Triptans for Migraine Headaches market. Further, it explains the major drivers and regional dynamics of the global Triptans for Migraine Headaches market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
Johnson & Johnson
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Triptans for Migraine Headaches Segment by Type
Oral
Subcutaneous Injection
Others
Triptans for Migraine Headaches Segment by Application
Hospital Pharmacies
Drug Stores
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Triptans for Migraine Headaches market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Triptans for Migraine Headaches, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Triptans for Migraine Headaches, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Triptans for Migraine Headaches, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Triptans for Migraine Headaches sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Triptans for Migraine Headaches market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Triptans for Migraine Headaches sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GSK, Teva, Pfizer, Novartis, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Merck and Johnson & Johnson, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Triptans for Migraine Headaches in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Triptans for Migraine Headaches manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Triptans for Migraine Headaches sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Triptans for Migraine Headaches Product Introduction
1.2 Market by Type
1.2.1 Global Triptans for Migraine Headaches Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Subcutaneous Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Triptans for Migraine Headaches Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Triptans for Migraine Headaches Sales Estimates and Forecasts 2017-2028
2.2 Global Triptans for Migraine Headaches Revenue Estimates and Forecasts 2017-2028
2.3 Global Triptans for Migraine Headaches Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Triptans for Migraine Headaches Sales by Region
2.4.1 Global Triptans for Migraine Headaches Sales by Region (2017-2022)
2.4.2 Global Sales Triptans for Migraine Headaches by Region (2023-2028)
2.5 Global Triptans for Migraine Headaches Revenue by Region
2.5.1 Global Triptans for Migraine Headaches Revenue by Region (2017-2022)
2.5.2 Global Triptans for Migraine Headaches Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Triptans for Migraine Headaches Sales by Manufacturers
3.1.1 Global Top Triptans for Migraine Headaches Manufacturers by Sales (2017-2022)
3.1.2 Global Triptans for Migraine Headaches Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Triptans for Migraine Headaches in 2021
3.2 Global Triptans for Migraine Headaches Revenue by Manufacturers
3.2.1 Global Triptans for Migraine Headaches Revenue by Manufacturers (2017-2022)
3.2.2 Global Triptans for Migraine Headaches Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Triptans for Migraine Headaches Revenue in 2021
3.3 Global Triptans for Migraine Headaches Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Triptans for Migraine Headaches Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Triptans for Migraine Headaches Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Triptans for Migraine Headaches Sales by Type
4.1.1 Global Triptans for Migraine Headaches Historical Sales by Type (2017-2022)
4.1.2 Global Triptans for Migraine Headaches Forecasted Sales by Type (2023-2028)
4.1.3 Global Triptans for Migraine Headaches Sales Market Share by Type (2017-2028)
4.2 Global Triptans for Migraine Headaches Revenue by Type
4.2.1 Global Triptans for Migraine Headaches Historical Revenue by Type (2017-2022)
4.2.2 Global Triptans for Migraine Headaches Forecasted Revenue by Type (2023-2028)
4.2.3 Global Triptans for Migraine Headaches Revenue Market Share by Type (2017-2028)
4.3 Global Triptans for Migraine Headaches Price by Type
4.3.1 Global Triptans for Migraine Headaches Price by Type (2017-2022)
4.3.2 Global Triptans for Migraine Headaches Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Triptans for Migraine Headaches Sales by Application
5.1.1 Global Triptans for Migraine Headaches Historical Sales by Application (2017-2022)
5.1.2 Global Triptans for Migraine Headaches Forecasted Sales by Application (2023-2028)
5.1.3 Global Triptans for Migraine Headaches Sales Market Share by Application (2017-2028)
5.2 Global Triptans for Migraine Headaches Revenue by Application
5.2.1 Global Triptans for Migraine Headaches Historical Revenue by Application (2017-2022)
5.2.2 Global Triptans for Migraine Headaches Forecasted Revenue by Application (2023-2028)
5.2.3 Global Triptans for Migraine Headaches Revenue Market Share by Application (2017-2028)
5.3 Global Triptans for Migraine Headaches Price by Application
5.3.1 Global Triptans for Migraine Headaches Price by Application (2017-2022)
5.3.2 Global Triptans for Migraine Headaches Price Forecast by Application (2023-2028)
6 North America
6.1 North America Triptans for Migraine Headaches Market Size by Type
6.1.1 North America Triptans for Migraine Headaches Sales by Type (2017-2028)
6.1.2 North America Triptans for Migraine Headaches Revenue by Type (2017-2028)
6.2 North America Triptans for Migraine Headaches Market Size by Application
6.2.1 North America Triptans for Migraine Headaches Sales by Application (2017-2028)
6.2.2 North America Triptans for Migraine Headaches Revenue by Application (2017-2028)
6.3 North America Triptans for Migraine Headaches Market Size by Country
6.3.1 North America Triptans for Migraine Headaches Sales by Country (2017-2028)
6.3.2 North America Triptans for Migraine Headaches Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Triptans for Migraine Headaches Market Size by Type
7.1.1 Europe Triptans for Migraine Headaches Sales by Type (2017-2028)
7.1.2 Europe Triptans for Migraine Headaches Revenue by Type (2017-2028)
7.2 Europe Triptans for Migraine Headaches Market Size by Application
7.2.1 Europe Triptans for Migraine Headaches Sales by Application (2017-2028)
7.2.2 Europe Triptans for Migraine Headaches Revenue by Application (2017-2028)
7.3 Europe Triptans for Migraine Headaches Market Size by Country
7.3.1 Europe Triptans for Migraine Headaches Sales by Country (2017-2028)
7.3.2 Europe Triptans for Migraine Headaches Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Triptans for Migraine Headaches Market Size by Type
8.1.1 Asia Pacific Triptans for Migraine Headaches Sales by Type (2017-2028)
8.1.2 Asia Pacific Triptans for Migraine Headaches Revenue by Type (2017-2028)
8.2 Asia Pacific Triptans for Migraine Headaches Market Size by Application
8.2.1 Asia Pacific Triptans for Migraine Headaches Sales by Application (2017-2028)
8.2.2 Asia Pacific Triptans for Migraine Headaches Revenue by Application (2017-2028)
8.3 Asia Pacific Triptans for Migraine Headaches Market Size by Region
8.3.1 Asia Pacific Triptans for Migraine Headaches Sales by Region (2017-2028)
8.3.2 Asia Pacific Triptans for Migraine Headaches Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Triptans for Migraine Headaches Market Size by Type
9.1.1 Latin America Triptans for Migraine Headaches Sales by Type (2017-2028)
9.1.2 Latin America Triptans for Migraine Headaches Revenue by Type (2017-2028)
9.2 Latin America Triptans for Migraine Headaches Market Size by Application
9.2.1 Latin America Triptans for Migraine Headaches Sales by Application (2017-2028)
9.2.2 Latin America Triptans for Migraine Headaches Revenue by Application (2017-2028)
9.3 Latin America Triptans for Migraine Headaches Market Size by Country
9.3.1 Latin America Triptans for Migraine Headaches Sales by Country (2017-2028)
9.3.2 Latin America Triptans for Migraine Headaches Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Triptans for Migraine Headaches Market Size by Type
10.1.1 Middle East and Africa Triptans for Migraine Headaches Sales by Type (2017-2028)
10.1.2 Middle East and Africa Triptans for Migraine Headaches Revenue by Type (2017-2028)
10.2 Middle East and Africa Triptans for Migraine Headaches Market Size by Application
10.2.1 Middle East and Africa Triptans for Migraine Headaches Sales by Application (2017-2028)
10.2.2 Middle East and Africa Triptans for Migraine Headaches Revenue by Application (2017-2028)
10.3 Middle East and Africa Triptans for Migraine Headaches Market Size by Country
10.3.1 Middle East and Africa Triptans for Migraine Headaches Sales by Country (2017-2028)
10.3.2 Middle East and Africa Triptans for Migraine Headaches Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Overview
11.1.3 GSK Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GSK Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GSK Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Overview
11.4.3 Novartis Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Recent Developments
11.5 Sun Pharma
11.5.1 Sun Pharma Corporation Information
11.5.2 Sun Pharma Overview
11.5.3 Sun Pharma Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sun Pharma Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sun Pharma Recent Developments
11.6 Grunenthal
11.6.1 Grunenthal Corporation Information
11.6.2 Grunenthal Overview
11.6.3 Grunenthal Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Grunenthal Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Grunenthal Recent Developments
11.7 Endo Pharmaceuticals
11.7.1 Endo Pharmaceuticals Corporation Information
11.7.2 Endo Pharmaceuticals Overview
11.7.3 Endo Pharmaceuticals Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Endo Pharmaceuticals Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo Pharmaceuticals Recent Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Overview
11.8.3 Merck Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Overview
11.9.3 Johnson & Johnson Triptans for Migraine Headaches Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson & Johnson Triptans for Migraine Headaches Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson & Johnson Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Triptans for Migraine Headaches Industry Chain Analysis
12.2 Triptans for Migraine Headaches Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Triptans for Migraine Headaches Production Mode & Process
12.4 Triptans for Migraine Headaches Sales and Marketing
12.4.1 Triptans for Migraine Headaches Sales Channels
12.4.2 Triptans for Migraine Headaches Distributors
12.5 Triptans for Migraine Headaches Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Triptans for Migraine Headaches Industry Trends
13.2 Triptans for Migraine Headaches Market Drivers
13.3 Triptans for Migraine Headaches Market Challenges
13.4 Triptans for Migraine Headaches Market Restraints
14 Key Findings in The Global Triptans for Migraine Headaches Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer